Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotronik trial milestones

This article was originally published in The Gray Sheet

Executive Summary

Biotronik enrolls the first patient July 23 in its 1,750-patient REPLACE registry, the first and largest prospective trial focusing on complications associated with replacements and system upgrades of FDA-approved implantable pacemakers and defibrillators. The registry will be conducted in 75 to 100 U.S. centers and will include all manufacturers' models. Also on July 23, Biotronik completed enrollment in its 1,000-patient TRUST study. The randomized, prospective trial is evaluating if patients with Lumos and Lumax VT-T/DR-T defibrillators followed by Biotronik's Home Monitoring and IEGM Online remote monitoring technology have outcomes at least equivalent to those receiving standard in-person follow up...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025062

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel